Cargando…
Small Molecule Antagonists of the Wnt/Beta-Catenin Signaling Pathway Target Breast Tumor-Initiating Cells in a Her2/Neu Mouse Model of Breast Cancer
BACKGROUND: Recent evidence suggests that human breast cancer is sustained by a minor subpopulation of breast tumor-initiating cells (BTIC), which confer resistance to anticancer therapies and consequently must be eradicated to achieve durable breast cancer cure. METHODS/FINDINGS: To identify signal...
Autores principales: | Hallett, Robin M., Kondratyev, Maria K., Giacomelli, Andrew O., Nixon, Allison M. L., Girgis-Gabardo, Adele, Ilieva, Dora, Hassell, John A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314694/ https://www.ncbi.nlm.nih.gov/pubmed/22470504 http://dx.doi.org/10.1371/journal.pone.0033976 |
Ejemplares similares
-
Serotonin transporter antagonists target tumor-initiating cells in a transgenic mouse model of breast cancer
por: Hallett, Robin M., et al.
Publicado: (2016) -
Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts
por: Gwynne, William D, et al.
Publicado: (2017) -
The Role of Serotonin in Breast Cancer Stem Cells
por: Gwynne, William D., et al.
Publicado: (2021) -
Breast Cancer and Her-2/Neu
por: Sherwood, Roy
Publicado: (2005) -
Activation Status of Wnt/ß-Catenin Signaling in Normal and Neoplastic Breast Tissues: Relationship to HER2/neu Expression in Human and Mouse
por: Khalil, Sara, et al.
Publicado: (2012)